Published in Clinical Oncology Week, October 2nd, 2006
Olanoff will continue to serve as a member of Celsion's board of directors. Anthony P. Deasey, Celsion's executive vice president, chief operating officer and chief financial officer has been named as interim chief executive officer of Celsion during the transitional period while a permanent chief executive officer is recruited. He will also be appointed to Celsion's board of directors.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.